Skip to main content
. 2021 Jul 24;43:100923. doi: 10.1016/j.nmni.2021.100923

Table 1.

Review of Clinical trials involving faecal microbial transplantation in treating extra-intestinal inflammatory disorders

Clinical trial identifier Disease/condition Trial status Sponsor Country
NCT02741518 Obesity Phase 1 Brigham and Women's Hospital USA
NCT02530385 Obesity Phase 2 Massachusetts General Hospital USA
NCT03926286 Sjogren's Syndrome Phase 1 University of Miami USA
NCT02255617 Hepatic Encephalopathy Phase 1 University of Alberta Canada
NCT02960074 Peanut allergy Phase 1 Boston Children's Hospital USA
NCT03594487 Relapsing-remitting MS Phase 1 University of California, San Francisco USA
NCT03998423 Alzheimer's disease (AD) Phase 1 University of Wisconsin, Madison USA
NCT03353402 Metastatic Melanoma Patients Who Failed Immunotherapy Phase 1 Sheba Medical Center USA
NCT03341143 Melanoma Melanoma University of Pittsburgh USA
NCT04014413 a variety of dysbiosis-associated disorder N/A Chinese University of Hong Kong China
NCT04251767 COVID-19 Complicated with Refractory Intestinal Infections N/A The Second Hospital of Nanjing Medical University China
NCT03058900 Psoriatic Arthritis Completed Odense University Hospital Denmark
NCT03279224 Bipolar Depression Phase 2: Allogenic
Phase 3: Autologous
Women's College Hospital Canada
NCT03281044 Major Depressive Disorder Melanoma Psychiatric Hospital of the University of Basel Switzerland

Abbreviations: USA: United States of America.